Samsung Asset Management (New York)’s AbbVie ABBV Stock Holding History

Samsung Asset Management (New York)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-27,268	Closed	-$1.61M	–	74
2015 Q4	$1.61M	Sell	27,268 -3,910	-13%	-$225K	0.65%	58
2015 Q3	$1.7M	Sell	31,178 -1,100	-3%	-$71.6K	0.65%	56
2015 Q2	$2.17M	Sell	32,278 -72,130	-69%	-$4.71M	0.73%	54
2015 Q1	$6.11M	Buy	104,408 +54,470	+109%	+$3.29M	2.03%	13
2014 Q4	$3.27M	Sell	49,938 -3,670	-7%	-$231K	1.09%	40
2014 Q3	$3.1M	Sell	53,608 -620	-1%	-$34.4K	0.97%	44
2014 Q2	$3.06M	Buy	54,228 +2,150	+4%	+$113K	0.95%	48
2014 Q1	$2.68M	Sell	52,078 -2,672	-5%	-$135K	0.94%	48
2013 Q4	$2.89M	Buy	54,750 +38,450	+236%	+$1.89M	0.96%	48
2013 Q3	$729K	Sell	16,300 -2,400	-13%	-$106K	0.86%	51
2013 Q2	$773K	Buy	+18,700	New	+$818K	0.9%	50

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Samsung Asset Management (New York)'s ABBV Position: Q1 2016 in Review

Samsung Asset Management (New York) sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 27,268 shares — an estimated $1.61M sold.

Samsung Asset Management (New York) first reported a position in ABBV in Q2 2013 and held it in 11 quarters. The position peaked at $6.11M in Q1 2015. 1,638 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Samsung Asset Management (New York) reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
Samsung Asset Management (New York) sold 27,268 AbbVie shares in Q1 2016, an estimated $1.61M.
Samsung Asset Management (New York) first reported a position in AbbVie in Q2 2013 and held it in 11 quarters.
Samsung Asset Management (New York)'s AbbVie position peaked at $6.11M in Q1 2015.
1,638 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Samsung Asset Management (New York)'s 13F filing for Q1 2016, filed 10 May 2016.